Patents by Inventor Stefanie Hahn

Stefanie Hahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Autoantibodies to Septin-7 and diagnosis of neurological disease
    Patent number: 11835519
    Abstract: A method for diagnosing a disease can include detecting, in a sample from a patient, an autoantibody binding to Septin-7. A polypeptide comprising Septin-7 or a variant thereof can be used for the diagnosis of a disease. Preferably, the polypeptide is used to detect an autoantibody binding to Septin-7 in a sample. A kit is useful for the diagnosis of a disease. The kit may include a polypeptide that includes Septin-7 or a variant thereof or a medical device that includes a polypeptide that includes Septin-7 or a variant thereof and an autoantibody to Septin-7.
    Type: Grant
    Filed: December 8, 2020
    Date of Patent: December 5, 2023
    Assignees: EUROIMMUN Medizinische Labordiagnostika AG, Mayo Foundation for Medical Education and Research
    Inventors: Ramona Miske, Madeleine Scharf, Lars Komorowski, Yvonne Denno, Stefanie Hahn, Christiane Radzimski, Mandy Unger, Andrew McKeon, Sean Pittock, Thomas Kryzer, Vanda Lennon, Josephe Honorat
  • Diagnosis of a neurological disease
    Publication number: 20210181196
    Abstract: A method for diagnosing a disease can include detecting, in a sample from a patient, an autoantibody binding to Septin-7. A polypeptide comprising Septin-7 or a variant thereof can be used for the diagnosis of a disease. Preferably, the polypeptide is used to detect an autoantibody binding to Septin-7 in a sample. A kit is useful for the diagnosis of a disease. The kit may include a polypeptide that includes Septin-7 or a variant thereof or a medical device that includes a polypeptide that includes Septin-7 or a variant thereof and an autoantibody to Septin-7.
    Type: Application
    Filed: December 8, 2020
    Publication date: June 17, 2021
    Applicants: EUROIMMUN Medizinische Labordiagnostika AG, Mayo Foundation for Medical Education and Research
    Inventors: Ramona MISKE, Madeleine Scharf, Lars Komorowski, Yvonne Denno, Stefanie Hahn, Christiane Radzimski, Mandy Unger, Andrew McKeon, Sean Pittock, Thomas Kryzer, Vanda Lennon, Josephe Honorat
  • Diagnosis of a neuroautoimmune disease
    Patent number: 10989712
    Abstract: A method is used for diagnosing a disease by detecting in a sample with antibodies from a patient an autoantibody binding to DAGLA.
    Type: Grant
    Filed: September 25, 2019
    Date of Patent: April 27, 2021
    Assignee: EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
    Inventors: Madeleine Scharf, Lars Komorowski, Ramona Miske, Stefanie Hahn, Yvonne Denno, Christian Probst, Farid Benkhadra
  • Diagnosis of a neuroautoimmune disease
    Publication number: 20200096506
    Abstract: A method is used for diagnosing a disease by detecting in a sample with antibodies from a patient an autoantibody binding to DAGLA.
    Type: Application
    Filed: September 25, 2019
    Publication date: March 26, 2020
    Applicant: EUROIMMUN Medizinische Labordiagnostika AG
    Inventors: Madeleine SCHARF, Lars Komorowski, Ramona Miske, Stefanie Hahn, Yvonne Denno, Christian Probst, Farid Benkhadra
  • Diagnosis of a neuroautoimmune disease comprising measuring autoantibodies to flotillin1 and/or flotillin2
    Patent number: 10138285
    Abstract: A method for diagnosing a disease by detecting an autoantibody that binds to flotillin1 and/or flotillin2 in a sample, a polypeptide comprising flotillin1 and/or flotillin2 or a variant thereof, which may be immobilized, a method of treating a disease by applying to a subject the polypeptide that binds to an autoantibody, an autoantibody binding to flotillin1 and/or flotillin2, a method for isolating the autoantibody, a pharmaceutical composition, a medical device and test kit comprising the polypeptide, are provided. A method for detecting the presence of an autoantibody is also provided.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: November 27, 2018
    Assignee: EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
    Inventors: Winfried Stoecker, Lars Komorowski, Madeleine Scharf, Ramona Miske, Yvonne Denno, Inga-Madeleine Dettmann, Christian Probst, Stefanie Hahn, Stephanie Kade, George Trendelenburg
  • DIAGNOSIS OF A NEUROAUTOIMMUNE DISEASE
    Publication number: 20160355565
    Abstract: A method for diagnosing a disease by detecting an autoantibody that binds to flotillin1 and/or flotillin2 in a sample, a polypeptide comprising flotillin1 and/or flotillin2 or a variant thereof, which may be immobilized, a method of treating a disease by applying to a subject the polypeptide that binds to an autoantibody, an autoantibody binding to flotillin1 and/or flotillin2, a method for isolating the autoantibody, a pharmaceutical composition, a medical device and test kit comprising the polypeptide, are provided. A method for detecting the presence of an autoantibody is also provided.
    Type: Application
    Filed: June 3, 2016
    Publication date: December 8, 2016
    Applicant: EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
    Inventors: Winfried STOECKER, Lars Komorowski, Madeleine Scharf, Ramona Miske, Yvonne Denno, Inga-Madeleine Dettmann, Christian Probst, Stefanie Hahn, Stephanie Kade, George Trendelenburg